Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma

被引：0
作者：
Xu Yang
Baofeng Lian
Nan Zhang
Junyu Long
Yiran Li
Jingnan Xue
Xiangqi Chen
Yunchao Wang
Yanyu Wang
Ziyu Xun
Mingjian Piao
Chenpei Zhu
Shanshan Wang
Huishan Sun
Zhijian Song
Leilei Lu
Xiaowei Dong
Aodi Wang
Wenjin Liu
Jie Pan
Xiaorong Hou
Mei Guan
Li Huo
Jie Shi
Haohai Zhang
Jinxue Zhou
Zhenhui Lu
Yilei Mao
Xinting Sang
Liqun Wu
Xiaobo Yang
Kai Wang
Haitao Zhao
机构：
[1] Peking Union Medical College Hospital,Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases
[2] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Breast Surgery
[3] OrigiMed Co.,Department of Radiology
[4] Ltd,Department of Radiotherapy
[5] Peking,Department of Medical Oncology
[6] Union Medical College Hospital,Department of Nuclear Medicine
[7] Chinese Academy of Medical Sciences & Peking Union Medical College,Department of Pathology
[8] Peking Union Medical College Hospital,Center for Inflammation Research, Department of Anesthesia, Critical Care & Pain Medicine
[9] Chinese Academy of Medical Sciences & Peking Union Medical College,Department of Hepatobiliary and Pancreatic Surgery
[10] Peking Union Medical College Hospital,Hepatobiliary and Pancreatic Surgery
[11] Chinese Academy of Medical Sciences & Peking Union Medical College,Liver Disease Center
[12] Peking Union Medical College Hospital,undefined
[13] Chinese Academy of Medical Sciences & Peking Union Medical College,undefined
[14] Peking Union Medical College Hospital,undefined
[15] Chinese Academy of Medical Sciences & Peking Union Medical College,undefined
[16] Peking Union Medical College Hospital,undefined
[17] Chinese Academy of Medical Sciences & Peking Union Medical College,undefined
[18] Beth Israel Deaconess Medical Center,undefined
[19] Harvard Medical School,undefined
[20] The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital,undefined
[21] Shenzhen Qianhai Shekou Free Trade Zone Hospital,undefined
[22] Affiliated Hospital of Qingdao University,undefined
来源：
BMC Medicine | / 22卷
关键词：
Microsatellite instability-high; Cholangiocarcinoma; PD-1 inhibitor; PD-L1 expression; Tumor mutation burden; Overall survival; Immune checkpoint inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Axillary cutaneous metastasis of colon cancer with microsatellite instability-high and BRAF V600E mutation treated with curative-intent surgery: a case report
    Daisuke Yamai
    Yoshifumi Shimada
    Hikaru Ozeki
    Akio Matsumoto
    Kaoru Abe
    Yosuke Tajima
    Mae Nakano
    Hiroshi Ichikawa
    Jun Sakata
    Toshifumi Wakai
    Surgical Case Reports, 9
  • [42] Nivolumab plus relatlimab in patients with previously treated microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 study
    Overman, Michael J.
    Gelsomino, Fabio
    Aglietta, Massimo
    Wong, Mark
    Limon Miron, Maria Luisa
    Leonard, Gregory
    Garcia-Alfonso, Pilar
    Hill, Andrew G.
    Cubillo Gracian, Antonio
    Van Cutsem, Eric
    El-Rayes, Bassel
    McCraith, Stephen M.
    He, Beilei
    Lei, Ming
    Lonardi, Sara
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (05)
  • [43] Rapid regression of microsatellite instability-high/programmed cell death ligand 1 -negative recurrent endometrial carcinoma by immune checkpoint blockade with pembrolizumab: A case report and literature review
    Takeda, Akihiro
    Koike, Wataru
    Watanabe, Kazuko
    GYNECOLOGIC ONCOLOGY REPORTS, 2020, 32
  • [44] First-line pembrolizumab plus androgen deprivation therapy for locally advanced microsatellite instability-high prostate cancer in a patient with Muir-Torre syndrome: A case report
    Atiq, Mohammad O.
    Pastor, Danielle M.
    Karzai, Fatima
    Hankin, Amy R.
    Turkbey, Baris
    Cordes, Lisa M.
    Brownell, Isaac
    Liu, Yi
    Chesnut, Gregory T.
    Madan, Ravi A.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [45] Envafolimab - first PD-1/PD-L1 antibody to be administered by subcutaneous injection for microsatellite instability-high or deficient mismatch repair advanced solid tumors
    Chen, Mifen
    Jiang, Mengyun
    Wang, Xinhui
    Shen, Lin
    Li, Jian
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (10) : 1227 - 1232
  • [46] Gene mutation profiling in microsatellite instability colorectal cancer and its association with the efficacy of immunotherapy: A retrospective study
    Liu, Ying
    Cui, Kang
    Ma, Wang
    CANCER MEDICINE, 2024, 13 (09):
  • [47] Going beyond microsatellite instability for immunotherapy in metastatic colorectal cancer: Consensus molecular subtypes and tumor mutational burden
    Cohen, Romain
    Heran, Maximilien
    Pudlarz, Thomas
    Hilmi, Marc
    Tournigand, Christophe
    Andre, Thierry
    Rousseau, Benoit
    BULLETIN DU CANCER, 2019, 106 (02) : 151 - 161
  • [48] Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumors display divergent genomic and transcriptomic profiles
    Simbolo, Michele
    Bersani, Samantha
    Vicentini, Caterina
    Taormina, Sergio, V
    Ciaparrone, Chiara
    Bagante, Fabio
    Rusev, Borislav
    Centonze, Giovanni
    Montresor, Marina
    Brunelli, Matteo
    Pedron, Serena
    Mafficini, Andrea
    Paolino, Gaetano
    Mattiolo, Paola
    Conci, Simone
    Milione, Massimo
    Guglielmi, Alfredo
    Ruzzenente, Andrea
    Scarpa, Aldo
    Luchini, Claudio
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2021, 25 (12) : 1095 - 1105
  • [49] Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study
    Andre, T.
    Shiu, K. -k.
    Kim, T. W.
    V. Jensen, B.
    Jensen, L. H.
    Punt, C. J. A.
    Smiths, D.
    Garcia-Carbonero, R.
    Alcaide-Garcia, J.
    Gibbs, P.
    de la Fouchardiere, C.
    Rivera, F.
    Elez, E.
    Le, D. T.
    Yoshino, T.
    Zuo, Y.
    Fogelmans, D.
    Adelbergs, D.
    Diaz, L. A.
    ANNALS OF ONCOLOGY, 2025, 36 (03) : 277 - 284
  • [50] Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142
    Andre, T.
    Lonardi, S.
    Wong, K. Y. M.
    Lenz, H. -J
    Gelsomino, F.
    Aglietta, M.
    Van Cutsem, E.
    McDermott, R.
    Hill, A.
    Sawyer, M. B.
    Hendlisz, A.
    Neyns, B.
    Abdullaev, S.
    Memaj, A.
    Lei, M.
    Dixon, M.
    Kopetz, S.
    Overman, M. J.
    Morse, M. A.
    ANNALS OF ONCOLOGY, 2022, 33 (10) : 1052 - 1060
12345